Clinical Trials
8 trialsNCT06941857 2026-05-05
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT04879368 2025-07-17
INTEGRATEIIb
Australasian Gastro-Intestinal Trials Group
Phase 3 Active not recruiting
NCT00545545 2025-03-19
Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
HiberCell, Inc.
Phase 1/2 Completed
NCT02539537 2024-01-09
NEOPAN
UNICANCER
Phase 3 Completed
NCT00816777 2018-09-07
PARAGON
Generic Devices Consulting, Inc.
Phase 1/2 Terminated
NCT00682786 2017-10-06
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Washington University School of Medicine
Phase 2 Completed
NCT02283359 2016-01-15
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT00192712 2010-11-10
Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
Rambam Health Care Campus
Phase 2/3 Completed